{"id":"tp-46564","type":"article-newspaper","title":"FDA Approves Inovio’s VOCERYQ to Reduce RRP Surgery Frequency","author":"Riza Dagoc","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/regulation/46564","datePublished":"2026-11-02T15:22:19.000Z","dateModified":"2026-11-02T15:22:19.000Z","language":"en","abstract":"In a 32-person study, seven of 26 patients in the efficacy group had no surgical excision during the 12 months after treatment.","section":"Regulation","references":[]}